EUROPEAN MULTIDISCIPLINARY ON UROLOGICAL CANCERS..
17th European Multidisciplinary Congress on Urological Cancers (EMUC2025)13 - 16 November 2025 Prague
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| P-003 | Factors Associated with Recurrence in Patients with Penile Cancer Treated with Partial Penectomy: An Analytical Study of an Institutional Cohort | Jose Gustavo Ramos Ulloa |  Received |
 |
|||
| O-004 | Real world evidence of adjuvant pembrolizumab in renal cell carcinoma (RCC) from a Spanish registry: The ARENAL trial from the GUARD consortium. | Natalia Vidal | Received |
|
|||
| P-011 | Single-Cell and Epigenomic Dissection Reveals ETS2 as a Master Regulator of Immunometabolic Macrophage States in Prostate BCC | Mierxiati Abudurexiti | Received |
|
|||
| P-015 | Pre-therapeutic onco-geriatric assessment improves prostate cancer care in elderly moroccans | Safaa Kriouile | Received |
|
|||
| P-019 | ROLE OF PSMA PET/MRI IN PROSTATE CANCER RECURRENCE AFTER PROSTATECTOMY | Karim Fard | Received |
|
|||
| P-027 | Prospective validation of diagnostic nomograms based on mass spectrometry-based urinary biomarkers to distinguish clinically significant prostate cancer: Complementing MRI pathway | Ana Cristina Morillo Tejedor | Received |
|
|||
| P-037 | Impact of Omitting Contralateral Biopsies on Risk Assessment in Unilateral Prostate Cancer | Stijn van den Bosch | Received |
|
|||
| P-039 | The mechanism behind the biochemical recurrence of localized prostate cancer after radical prostatectomy: A systematic review | Che Hsueh Yang | Received |
|
|||
| P-054 | POPS: a randomised trial of image-guided prostate bed radiotherapy using the rectal obturator ProSpare® (NCT02978014): acute toxicity and dosimetry | Sarah Stewart | Received |
|
|||
| P-057 | Post hoc analyses of symptomatic skeletal events (SSEs) in patients (pts) with non-metastatic hormone-sensitive prostate cancer (nmHSPC) in EMBARK and metastatic HSPC (mHSPC) in ARCHES treated with enzalutamide (ENZA) | Anna George | Received |
|
|||
| P-066 | Secondary neurovascular bundle resections in NeuroSAFE-guided radical prostatectomy: rarely tumor-positive | Joost van Drumpt | Received |
|
|||
| P-068 | US-guided Targeted Focal Salvage Cryoablation: a precise and low-morbidity approach for local recurrence after radiotherapy in prostate cancer | Emanuela Altobelli | Received |
|
|||
| P-075 | Salvage HDR-Brachytherapy for Prostate Cancer Recurrence: Outcomes, Predictors, and Toxicity Profile in a PSMA-PET Selected Cohort | Mateusz Bilski | Received |
|
|||
| P-090 | Identifying candidates for watchful waiting in prostate cancer | Keren Rouvinov | Received |
|
|||
| P-105 | Interim analysis of the PROVIDENCE study: An AI-based model for predicting metastatic recurrence in localized prostate cancer patients using quantitative imaging biomarkers and clinical data | Anna Nogué Infante | Received |
|
|||
| P-112 | Multicentre retrospective comparison of definitive EBRT with or without HDR brachytherapy boost in patients with locally-advanced prostate cancer and regional lymph node metastases – a propensity score matched analysis | Mateusz Bilski | Received |
|
|||
| P-113 | Tailoring Nodal Radiotherapy in Regionally Advanced Prostate Cancer: A Multicenter Study of Dose Escalation Outcomes Based on PSMA PET vs. Conventional Imaging | Mateusz Bilski | Received |
|
|||
| P-114 | Matching-adjusted indirect comparison (MAIC) between enzalutamide (ENZA) and apalutamide (APA) with androgen-deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC) | Anna George | Received |
|
|||
| P-117 | Moderately hypofractionated radiotherapy for high-risk and very high-risk prostate cancer | Martin Palkovsky | Received |
|
|||
| P-121 | Early findings from the STARR (NCT05455736) trial: Stereotactic salvage radiotherapy for macroscopic recurrence in the prostate bed post-prostatectomy | Niccolo Bertini | Received |
|
|||
| P-126 | Patient Relevance of Intermediate Clinical Endpoints in Prostate Cancer: An International Cross-Sectional Online Survey | Barbara Anderson | Received |
|
|||
| P-133 | Prognostic Utility of Dynamic PSMA PET/CT and Kinetic Modeling with LAFOV in Advanced Prostate Cancer | Andrea Di Giorgio | Received |
|
|||
| P-135 | Re-defining predictive models for Lymph Node Hormone Sensitive metastatic Prostate Cancer (HSPCm1a): "Beyond Time to Metastasis" | Fernando Alberca Del Arco | Received |
|
|||
| P-143 | Overcoming Barriers to Precision Oncology in Latin America: ctDNA-Based HRR Mutation Testing in mPCa | Gonzalo Taetti | Received |
|
|||
| P-145 | Sample age is correlated with increased failure rates in NGS testing. Auditing our institutions prostate cancer patients undergoing genomic testing for BRCA1/2 | Benjamin Ball | Received |
|
|||
| P-150 | Effect Modifiers in Metastatic Castration-Sensitive Prostate Cancer: An Overview of Reviews | Rebekah Ashford | Received |
|
|||
| P-151 | Effectiveness of a Personalized Strength Training Program (SPORT-MU) on Fatigue in Prostate Cancer Patients Under Androgen Deprivation Therapy | Enrique Cao Avellaneda | Received |
|
|||
| P-153 | Prognostic factors for patients undergoing ADT and ARPI doublet therapy for metastatic hormone sensitive prostate cancer | Alex Batty | Received |
|
|||
| P-155 | Estimating Median Overall Survival (OS) of Darolutamide in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Statistical Extrapolation from the ARASENS Study | Chelsea Cunningham | Received |
|
|||
| P-156 | Prostate-specific antigen (PSA) response with apalutamide in patients with metastatic castration-sensitive prostate cancer in real-world: a retrospective cohort study - PSAPA study | Maria Ines Teodoro | Received |
|
|||
| P-165 | The Predictors Of Response to Metastasis-Directed Therapy with SBRT in PSMA PET/CT staged oLigorecurrent prostate cancer (PORTAL) Study: Development and External Validation of a Nomogram-based Risk Classification | Timo Soeterik | Received |
|
|||
| P-166 | Real-World Treatment Patterns in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) in Europe and Asia between 2020 and 2024 | Lucy Williamson | Received |
|
|||
| P-167 | Synergistic effects of radiotherapy and apalutamide in PSA reduction | José María Nieto-Guerrero Gómez | Received |
|
|||
| P-170 | Real-World Treatment Patterns in Men with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Europe and Asia from 2020 to 2024 | Lucy Williamson | Received |
|
|||
| P-179 | Bridging gaps in advanced prostate cancer care: Impact of a micro-learning online education initiative to future-proof practice | Ben Johnson | Received |
|
|||
| P-182 | Safety Profile and Toxicity Spectrum of Novel Antiandrogens in Metastasic Hormone-Sensitive Prostate Cancer: Real Worls Insights | Ismail Zarrud | Received |
|
|||
| P-183 | Outcomes of Multimodal Treatment in Oligometastatic Prostate Cancer: Five Years of Single-Centre Experience | Tin Rosan | Received |
|
|||
| P-186 | Impact of Androgen Receptor Pathway Inhibitors on Muscle Mass in Patients with Advanced Prostate Cancer | Jaime Jorge Tufet Jaumot | Received |
|
|||
| P-193 | Timing matters: Circadian impact of ipilimumab–nivolumab in 30 patients with clear cell RCC | Ivan Bivolarski | Received |
|
|||
| P-195 | Radiomics and Image-Based Artificial Intelligence for Predicting Recurrence and Survival After Surgery in Localized Renal Cell Carcinoma: An APPRAISE-AI Systematic Review and Meta-Analysis | Georges Mjaess | Received |
|
|||
| P-197 | Could chronic cough be a presenting symptom of kidney cancer? | Wendy Smith | Received |
|
|||
| P-199 | Impact of renal tumor biopsies in preventing unnecessary treatment for cT1 renal cell carcinoma: A multi-institutional analysis | Luuk de Haan | Received |
|
|||
| P-204 | Final analysis of lenvatinib + pembrolizumab vs sunitinib in patients with advanced renal cell carcinoma with or without bone metastases in CLEAR | Laura Hendrickson | Received |
|
|||
| P-210 | Complications of Robot-Assisted Partial Nephrectomy: Current Status in France (UroCCR 215) | Dimitri Paillusson | Received |
|
|||
| P-213 | Activity and Safety of First-Line Treatments for Metastatic Renal Cell Carcinoma in older Patients, Gustave Roussy experience | Maxime Frelaut | Received |
|
|||
| P-222 | Stereotactic Body Radiotherapy for Localized Renal Cell Carcinoma Compared with Standard Surgery: A Retrospective Analysis from the Young Academic Urologists (YAU) Working Group Database | Michele Aquilano | Received |
|
|||
| P-223 | Assessment of advanced clear cell renal cancer patients treated with first-line immuno-combinations: a monocentric Latin American experience | Martin Ignacio Zapata Laguado | Received |
|
|||
| P-234 | Health-related quality of life in localised and metastatic renal cell carcinoma: insights from patient-reported outcome measures | Matthijs Duijn | Received |
|
|||
| P-236 | Physical rehabilitation method in patients with Renal cell carcinoma undergoing immunotherapy | Joint group | Received |
|
|||
| P-237 | Prospective evaluation of the performance of Mi371 test under real life conditions for the diagnosis of testicular germ cell cancer | Carolina DElia | Received |
|
|||
| P-240 | Efficacy and Safety of Salvage Chemotherapy with Gemcitabine, Oxaliplatin, and Paclitaxel (GOP) for Germ Cell Cancer in Japanese Patients | Takeshi Kishida | Received |
|
|||
| P-242 | Comprehensive Outcomes of Robot-Assisted Retroperitoneal Lymph Node Dissection Across Various Treatment Indications | Pia Kraft | Received |
|
|||
| P-247 | In vitro studying of the anticancer effects of pyrimethamine on the human bladder cancer cells | Che Hsueh Yang | Received |
|
|||
| P-250 | Immune Exhaustion Following BCG Failure in NMIBC: Evidence from in vitro and Tumor Gene Expression Analyses | Yonaton Zarbiv | Received |
|
|||
| P-252 | Pre-therapeutic onco-geriatric assessment optimizes chemotherapy in elderly moroccans with advanced bladder cancer | Safaa Kriouile | Received |
|
|||
| P-259 | Next generation OCT imaging for UCC – First in-human results | Philip Oldenburg | Received |
|
|||
| P-260 | Radiomic Signature of Bladder Cancer in Correlation with Muscle Invasiveness | Mieszko Kozikowski | Received |
|
|||
| P-270 | A comparative study of two surgical robotic systems for perioperative outcomes of robot-assisted radical cystectomy: a propensity score-matched analysis | HIROMITSU WATANABE | Received |
|
|||
| P-272 | Team Familiarity: Renal, Bladder and Prostate Cancer surgery outcomes with respect to team composition | Imogen Roberts | Received |
|
|||
| P-273 | Real-world epidemiology and treatment patterns for high-risk non–muscle invasive bladder cancer in Spain: findings from the BLARWE study | Tamara Pozo | Received |
|
|||
| P-274 | Impact of Neoadjuvant Chemotherapy Dose Intensity on Pathological Response and Survival in Muscle-Invasive Urothelial Carcinoma | Carmine Caso | Received |
|
|||
| P-285 | Molecular landscape of metastatic bladder cancer and response to systemic therapy and immunotherapy: a two-year single-center experience | Mariia Gusakova | Received |
|
|||
| P-300 | Real-world Experience with Enfortumab Vedotin as Palliative Therapy in Advanced Urothelial Carcinoma after Progression to Platinum-based Chemotherapy and Immune Checkpoint Inhibitors | José Antonio Folgueira Vigo | Received |
|
|||
| P-302 | Is There Still a Role for Ureteral Frozen Section Analysis During Radical Cystectomy? A Single-Center Retrospective Analysis | Attilio Barretta | Received |
|
|||
| P-308 | Hematological inflammatory markers predict time to BCG failure in high-risk non-muscle-invasive bladder cancer | Kiril Zhelev | Received |
|
|||
| P-310 | A Retrospective Study of the Diagnostic Performance of CT Urography vs. Ureterorenoscopy in the Follow-up Setting of Kidney-Sparing Surgery for Upper Tract Urothelial Carcinoma | Orlane Figaroa | Received |
|
|||
| P-311 | The Effect Of Intravesical BCG On Recurrence And Progression In Synchronous /Metachronous Bladder Tumors Accompanying Upper Urinary Tract Tumors | Ertürk Altun | Received |
|
|||
| P-326 | Shared decision-making in Urology: Consensus and Challenges identified by the joint Patient Advocates, Nurses and Urologists from the EAU Patient Office | Esther Robijn | Received |
|
|||
| P-329 | From R0 to reconstruction: Urology´s role in Pelvic Exenteration Surgery for Locally Advanced and Recurrent Colorectal Cancer | Maryam Raya Ibrahim Rasheed | Received |
|
|||
17th European Multidisciplinary Congress on Urological Cancers (EMUC2025)
13 - 16 November 2025 Prague
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 13/11/2025 TO 13/11/2025
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
|
|
